Therefore, the enhancement of CAT activity by the HMH peptides, especially in the adult rats, could also have contributed to the observed decrease in plasma TPx levels, which can decrease the risk or pathological intensity of cardiovascular disease. This evidence concerns the gene TPO and cardiovascular disorder.